Phoenix Select Regulatory Consulting, a provider of GxP auditing, inspection readiness, regulatory consulting, and quality assurance services for the life sciences industry, is proud to announce that Jim Birney has joined the company as Director of Project Management. Birney brings more than three decades of experience across the pharmaceutical, healthcare, and professional services industries, with a background in global project management, business operations, client relationship management, and strategic program development.
In his new role, Birney will oversee project management activities, coordinate auditor assignments for GxP engagements, support client relationships, and contribute to business development initiatives. He will work closely with Phoenix Select founder and Chief Auditor Barbara Rusin, MS, to support the firm’s expanding network of experienced auditors and ensure that client engagements are managed effectively.
“Jim brings extensive experience managing complex projects, building strong client relationships, and coordinating highly specialized teams,” said Rusin. “His understanding of the pharmaceutical industry and commitment to dependable execution make him a valuable addition as we continue expanding our services and supporting clients around the world.”
Prior to joining Phoenix Select, Birney spent nearly nine years with MMS, a global clinical research organization (CRO), where he served as Senior Manager of Project Management and Operations. In this role, he managed internal and external projects, coordinated senior-level consultants, supported strategic initiatives, and worked across medical writing and regulatory affairs operations. His responsibilities also included contract management and supporting new business partnerships.
“Phoenix Select has a tremendous foundation built on deep regulatory expertise and a commitment to quality,” said Birney. “I’m excited to help take the company to the next level by expanding our global auditor network, strengthening client relationships, and building the operational capabilities needed to support our continued growth. We have a real opportunity to make a meaningful difference for the organizations we serve.”
Earlier in his career, Birney served as Director of Clinical Site Development at Asterand Bioscience, where he led efforts to establish clinical donor networks supporting the National Cancer Institute’s Cancer Genome Atlas Program. His work involved developing relationships with hospitals and research institutions, coordinating institutional review board approvals, and supporting collaborations that advanced cancer research.
Birney also held leadership positions with Kelly Services, including Global Client Relationship Manager and Regional Director, overseeing major client relationships and large-scale operations across multiple states. He began his pharmaceutical career with The Upjohn Company, and he holds a Bachelor of Science in Microbiology from Michigan State University.
His appointment supports Phoenix Select’s continued development of a global auditing network and its commitment to providing life sciences organizations with experienced professionals who understand the operational and regulatory demands of drug development.
About Phoenix Select Regulatory Consulting
Phoenix Select Regulatory Consulting provides GxP auditing, inspection readiness, regulatory consulting, remediation, and quality management system services to pharmaceutical, biotechnology, clinical research, and other life sciences organizations. Led by founder and Chief Auditor Barbara Rusin, MS, a former FDA investigator, Phoenix Select combines regulatory experience with a global network of qualified auditors to help organizations identify risks early, strengthen quality systems, and support informed decisions throughout the development lifecycle. Learn more at www.phoenixselect.com.
Media Contact
Don F. McLean, McLean Media
+1-734-716-4182
